🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Carl Morrison MD of Ctr for Personalized Med, RPCI, at #ahcj14 - Lung cancer is leading the way in personalized medicine

Welcome! The LungCARD consortium is a partnership of European Enterprises and Universities committed to improving lung cancer diagnosis.

Nanotechnology to fight cancer: horizon-magazine.eu/article/nanote…

EGFR mutations detection in non-small-cell lung cancer patients, our proposed solution:

You're welcome, CancerFightClub.

Thanks for following, CETI.

Thanks for following us, C. Michael Gibson MD.

Dissemination activity University of Hull : lungcard.eu/common_page.ph…

Our poster Precision Med TRI-CON 2014:lungcard.eu/pdfs_others/Go…

Novartis Gets FDA Approval for Zykadia, for ALK-Positive NSCLC Patients already treated with Xalkori.

Every five minutes a woman in the U.S. is told she has #lungcancer. Change starts today. #LUNGFORCE bit.ly/PrbGKz